Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gradient Labs›
Analysis
AddedJun 1, 2026
UpdatedJun 1, 2026
Gradient Labs

Gradient Labs

Series A Extension

Gradient Labs builds compliant AI agents for financial services customer operations.

HQ
London, England, GB
Founded
2023
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Executive Summary
  2. 02Products & Services
  3. 03Market Outlook
  4. 04Competitive Strengths
  1. 01Executive Summary
  2. 02Products & Services
  3. 03Market Outlook
  4. 04Competitive Strengths

Memo

Gradient Labs represents a compelling opportunity in the AI customer operations space, founded by three former Monzo executives with direct experience building data science and ML teams in a regulated banking environment. The company has demonstrated strong early traction, securing a landmark deployment with one of the UK's largest regulated banks and achieving higher CSAT scores than human agents.

Financially, Gradient Labs has raised approximately $30M total across seed and Series A rounds, with notable investors including Redpoint Ventures, Octopus Ventures, CommerzVentures, LocalGlobe, and Exceptional Capital. The company's focus on financial services provides a defensible niche, though expansion into back-office operations and US markets will be critical for achieving venture-scale returns.

Product Overview

Gradient Labs builds an AI-native customer operations platform specifically designed for regulated industries, with a deep focus on financial services. The platform deploys autonomous AI agents that learn company-specific products and processes through structured knowledge graphs, enabling them to handle complex customer inquiries reliably and safely.

Unlike generalist chatbot solutions, Gradient Labs' agents follow standard operating procedures (SOPs) and can resolve both frontline customer support and back-office operational tasks. The company claims its AI consistently achieves higher Customer Satisfaction (CSAT) scores than human agents while maintaining superior compliance measured by internal Quality Assurance reviews.

Market Outlook

The market for AI-powered customer operations in financial services is expanding rapidly as banks and fintechs face mounting pressure to reduce support costs while meeting rising customer expectations for instant service. Despite businesses paying up to $13.50 per customer service interaction, 66% of customers expect responses within minutes and one in three will abandon a brand after a single poor experience.

Gradient Labs is well-positioned to capture share in this market because most existing AI tools only handle simple frontline queries, leaving the complex 80% of operational processes untouched. The company's early traction with major UK banks and European fintechs, combined with its planned US expansion, suggests significant growth runway in a market where in-house automation efforts have largely underdelivered.

Competitive Advantages

Gradient Labs' core competitive advantage stems from its founding team's deep domain expertise in financial services operations, built through years at Monzo building AI and data science teams. This insider knowledge enables the company to design agents that understand the nuanced compliance, fraud, and regulatory requirements that generalist AI support tools fail to address.

The company's technical architecture is differentiated by its knowledge graph approach rather than simple LLM wrappers, allowing agents to reason through ambiguous inputs and ask clarifying questions. Gradient Labs also offers a bold quality guarantee through its $10,000 challenge, demonstrating confidence that its platform outperforms alternatives in head-to-head trials.